BioNTech CEO Prof. Dr. Ugur Sahin – der Hauptgrund für zu wenig Impfstoff ist dass sich die EU zu geringen Mengen gesichert hat
This entry was posted on Freitag, Januar 1st, 2021 at 16:17 and is filed under Administration. You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.